Breast Cancer Nomograms: Prediction for a Low-risk and a High-risk Oncotype DX Recurrence Score
The current calculator is being updated. It is expected to be back in service by April 25, 2019. Please see the publication below for the paper version of the calculator. We apologize for any inconvenience.
Orucevic A, Bell JL, McNabb AP, Heidel RE (2017) Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data. Breast Cancer Research and Treatment 163 (1):51-61. doi:10.1007/s10549-017-4170-3.
This website and the nomograms are provided for general health information only and are not to be used as a substitute for diagnosis or medical advice. All questions should be addressed directly to your individual healthcare provider. In using this website and the nomograms, you agree that neither The University of Tennessee Medical Center ("UTMC") nor any other party is or will be liable or otherwise responsible for any decision made, or any action taken, or any action not taken due to your use of any information presented in the nomograms.
Use of this website including the nomograms does not create an expressed or implied physician-patient relationship.
UTMC does not assume any risk for your use of website and/or its nomograms or the information contained herein. UTMC makes no warranties or representations, expressed or implied, regarding the accuracy, completeness, timeliness, or usefulness of any information contained or referenced in the website and/or the nomograms.
You are advised to consult with a healthcare provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any healthcare problem or issue you might have at any time, now or in the future.